Drug
Bevacizumab-bvzr
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Neoplasm Progression | 82 | 71.4 | 80.9 | signal |
| 2 | Poor Venous Access | 16 | 47.3 | 48.4 | signal |
| 3 | Blood Pressure Systolic Increased | 26 | 40.5 | 42.0 | signal |
| 4 | Blood Pressure Fluctuation | 26 | 33.0 | 34.2 | signal |
| 5 | Intestinal Perforation | 12 | 32.6 | 33.1 | signal |
| 6 | Weight Fluctuation | 10 | 29.3 | 29.7 | signal |
| 7 | Lymphocyte Count Decreased | 13 | 22.4 | 22.8 | signal |
| 8 | Hemiparesis | 9 | 16.1 | 16.3 | signal |
| 9 | Brain Neoplasm | 4 | 13.3 | 13.3 | signal |
| 10 | Posterior Reversible Encephalopathy Syndrome | 4 | 12.8 | 12.9 | signal |
| 11 | Metastases To Lung | 4 | 10.6 | 10.6 | signal |
| 12 | Myelodysplastic Syndrome | 5 | 10.5 | 10.6 | signal |
| 13 | Colon Cancer | 5 | 10.2 | 10.3 | signal |
| 14 | Malignant Neoplasm Progression | 22 | 6.6 | 6.8 | signal |